| Urban air pollution and mortality in a cohort of Norwegian men. P Nafstad, LL Håheim, T Wisløff, F Gram, B Oftedal, I Holme, I Hjermann, ... Environmental health perspectives 112 (5), 610-615, 2004 | 363 | 2004 |
| Cancer risk with folic acid supplements: a systematic review and meta-analysis TN Wien, E Pike, T Wisløff, A Staff, S Smeland, M Klemp BMJ open 2 (1), e000653, 2012 | 242 | 2012 |
| Prevalence, employment rate, and cost of schizophrenia in a high-income welfare society: a population-based study using comprehensive health and welfare registers S Evensen, T Wisløff, JU Lystad, H Bull, T Ueland, E Falkum Schizophrenia bulletin 42 (2), 476-483, 2016 | 238 | 2016 |
| Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010 T Wisløff, G Hagen, V Hamidi, E Movik, M Klemp, JA Olsen Pharmacoeconomics 32, 367-375, 2014 | 195 | 2014 |
| Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years L Lund Håheim, TF Wisløff, I Holme, P Nafstad American journal of epidemiology 164 (8), 769-774, 2006 | 195 | 2006 |
| Transparent development of the WHO rapid advice guidelines HJ Schünemann, SR Hill, M Kakad, GE Vist, R Bellamy, L Stockman, ... PLoS medicine 4 (5), e119, 2007 | 170 | 2007 |
| Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program T Wisløff, TG Abrahamsen, MAR Bergsaker, Ø Løvoll, P Møller, ... Vaccine 24 (29-30), 5690-5699, 2006 | 88 | 2006 |
| Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19 AH Briggs, DA Goldstein, E Kirwin, R Meacock, A Pandya, DJ Vanness, ... Health Economics 30 (3), 699-707, 2021 | 75 | 2021 |
| Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia LJ Mundal, J Igland, MB Veierød, KB Holven, L Ose, RM Selmer, T Wisloff, ... Heart 104 (19), 1600-1607, 2018 | 71 | 2018 |
| Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting M Korman, T Wisløff European Heart Journal–Cardiovascular Pharmacotherapy 4 (1), 15-22, 2018 | 69 | 2018 |
| Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation T Wisløff, G Hagen, M Klemp Pharmacoeconomics 32, 601-612, 2014 | 67 | 2014 |
| More use of peritoneal dialysis gives significant savings: a systematic review and health economic decision model E Pike, V Hamidi, T Ringerike, T Wisloff, M Klemp Journal of clinical medicine research 9 (2), 104, 2017 | 66 | 2017 |
| Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report OL Mandrik, JLH Severens, A Bardach, S Ghabri, C Hamel, T Mathes, ... Value in Health 24 (4), 463-472, 2021 | 61 | 2021 |
| Lung function increases with increasing level of physical activity in school children S Berntsen, T Wisløff, P Nafstad, W Nystad Pediatric exercise science 20 (4), 402-410, 2008 | 61 | 2008 |
| Cognitive patient education for low back pain in primary care: a cluster randomized controlled trial and cost-effectiveness analysis EL Werner, K Storheim, I Løchting, T Wisløff, M Grotle Spine 41 (6), 455-462, 2016 | 57 | 2016 |
| Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction R Selmer, S Halvorsen, KI Myhre, TF Wisløff, IS Kristiansen Scandinavian Cardiovascular Journal 39 (5), 276-285, 2005 | 43 | 2005 |
| Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden A Bergman, J Hjelmgren, Å Örtqvist, T Wisløff, I Sønbø Kristiansen, ... Scandinavian journal of infectious diseases 40 (9), 721-729, 2008 | 42 | 2008 |
| Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood SKH Bøhn, L Thorsen, CE Kiserud, SD Fosså, HC Lie, JH Loge, T Wisløff, ... Acta Oncologica 58 (5), 753-762, 2019 | 41 | 2019 |
| Long-term, self-reported health outcomes in kidney donors K Meyer, AK Wahl, IT Bjørk, T Wisløff, A Hartmann, MH Andersen BMC nephrology 17, 1-10, 2016 | 41 | 2016 |
| Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease-A cost-effectiveness analysis T Wisløff, RM Selmer, S Halvorsen, A Fretheim, OF Norheim, ... BMC cardiovascular disorders 12, 1-12, 2012 | 40 | 2012 |
Ivar S KristiansenProfessor of community medicine University of Oslo在 medisin.uio.no 的电子邮件经过验证
